Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacyAnil H. Kadam, Jan E. Schnitzer|PLoS ONE|2022Cited by 10
Insights into Disease Progression of Translational Preclinical Rat Model of Interstitial Pulmonary Fibrosis through Endpoint AnalysisAnil H. Kadam, Jan E. Schnitzer|Cells|2024Cited by 10
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacyAnil H. Kadam, Jan E. Schnitzer|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 3